The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · Real-Time Price · USD
27.38
+0.08 (0.29%)
Dec 20, 2024, 4:00 PM EST - Market closed
The Pennant Group Market Cap
The Pennant Group has a market cap or net worth of $940.46 million as of December 20, 2024. Its market cap has increased by 136.11% in one year.
Market Cap
940.46M
Enterprise Value
1.31B
1-Year Change
136.11%
Ranking
Category
Stock Price
$27.38
Market Cap Chart
Since October 1, 2019, The Pennant Group's market cap has increased from $422.52M to $940.46M, an increase of 122.58%. That is a compound annual growth rate of 16.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 940.46M | 125.76% |
| Dec 29, 2023 | 416.58M | 27.84% |
| Dec 30, 2022 | 325.85M | -50.42% |
| Dec 31, 2021 | 657.25M | -59.84% |
| Dec 31, 2020 | 1.64B | 77.73% |
| Dec 31, 2019 | 920.89M | 117.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 981.70M |
| Avadel Pharmaceuticals | 974.22M |
| Owens & Minor | 973.12M |
| HealthStream | 948.64M |
| Zymeworks | 935.36M |
| Poseida Therapeutics | 917.16M |
| Gyre Therapeutics | 914.87M |
| Nuvation Bio | 905.36M |